Akèy › Maladi atè perifèrik › Tennessee
Etid klinik pou Maladi atè perifèrik nan Tennessee
14 etid pou Maladi atè perifèrik ap chèche patisipan nan sit nan Tennessee.
Vil nan Tennessee
Tèks ofisyèl etid la (Anglè)
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Apex Research Foundation, LLC, Jackson
- Tennova TCMC, Knoxville
- Vanderbilt Heart and Vascular Tullahoma, Cardiology and Vascular Associates, Tullahoma
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07318610Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- The Jackson Clinic, Jackson
- East Coast Institute for Research - Jefferson City, Jefferson City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07223593Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Southeast Renal Research Institute, Chattanooga
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
- ak 2 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- Tennessee Center for Clinical Trials, Tullahoma
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06321575The THOR IDE Study
- Vascular Institute of Chattanooga, Chattanooga
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT05916950The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
- Wellmont Holston Valley Medical Center, Kingsport
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT05811364REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center
- University of Tennessee Medical Center, Knoxville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT07223437SELUTION4BTK Trial
- Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 28, 2026 · NCT05055297PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
- Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 18 a 95 · Tout sèks · Mizajou Apr 16, 2026 · NCT05313165Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04774159Randomized Clinical Trial for Ewing Amputation in the VA
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Ap rekrite
Tout laj · Tout sèks · Mizajou Feb 9, 2026 · NCT05437562Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
- Wellmont CVA Heart Institute, Kingsport
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Feb 6, 2026 · NCT01904851Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Memphis VA Medical Center, Memphis, TN, Memphis
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT02915198Pounce™ Thrombectomy System Retrospective Registry
- Vanderbilt University Medical Center, Nashville
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2025 · NCT05868161Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.